Priority Claims Cannot Be Incorporated by Reference -
In Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited, Appeal Nos. 2016-2707 and 2016-2708, the Federal Circuit held that when a patent for a...more
6/25/2018
/ Abbreviated New Drug Application (ANDA) ,
Abuse of Discretion ,
Appeals ,
Claim Construction ,
Clear Error Standard ,
Consolidated Appeals ,
Diagnostic Method ,
Disclaimers ,
Discovery ,
Extrinsic Evidence ,
Generic Drugs ,
Incorporation by Reference ,
Injunctive Relief ,
Inter Partes Review (IPR) Proceeding ,
Jurisdiction ,
Patent Infringement ,
Patent Invalidity ,
Patent Terms ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Priority Patent Claims ,
Privity of Contract ,
Product of Nature Doctrine ,
Real Party in Interest ,
Scope of the Claim ,
Subsequent Litigation ,
Time-Barred Claims ,
Treatment Method Patents
District Court Abused Discretion in Ignoring Federal Circuit Mandate to Reconsider Attorneys’ Fees Under Octane Fitness -
In Adjustacam, LLC v. Newegg, Inc., Appeal No. 2016-1882, the Federal Circuit held that a district...more
9/15/2017
/ Abuse of Discretion ,
Adverse Inference Instructions ,
Appeals ,
Attorney's Fees ,
Broadest Reasonable Interpretation Standard ,
Damages ,
Discovery ,
Discovery Disputes ,
Document Productions ,
Exceptional Case ,
Inter Partes Review (IPR) Proceeding ,
Judicial Mandates ,
Means-Plus-Function ,
Motion to Compel ,
Obviousness ,
Octane Fitness v. ICON ,
Patent Infringement ,
Patent Invalidity ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Reaffirmation ,
Remand ,
Reversal ,
Sanctions ,
Standard of Review ,
Totality of Circumstances Test ,
USPTO ,
Willful Misconduct
The pressures of global litigation have forced litigants to further consider how, when, and where they will obtain discovery. Under developing case law, litigants involved in related litigations in different venues should...more